Indium (111In) biciromab
From Infogalactic: the planetary knowledge core
| Monoclonal antibody | |
|---|---|
| Type | Fab' fragment |
| Source | Mouse |
| Target | Fibrin II, beta chain |
| Clinical data | |
| Trade names | FibriScint |
| Pregnancy category |
|
| Legal status |
|
| Identifiers | |
| CAS Number | 138783-13-8  |
| ATC code | none |
| KEGG | D03111  |
| (what is this?) (verify) |
|
Indium (111In) biciromab (INN, trade name FibriScint, developed by Centocor) was a drug targeting fibrin, a protein involved in the clotting of blood.[1] It was the Fab' fragment of a mouse monoclonal antibody labelled with the radioisotope indium-111 for the diagnosis of thromboembolism,[2] but was withdrawn during clinical trials.[3]
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Answers.com: Centocor Ortho Biotech Products, L.P.
- ↑ DiagnosticImaging.com: Centocor withdraws imaging agent applications
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |
